﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>48</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>08</Month>
        <DAY>03</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Engineering of multifunctional nanocarriers based on biopolymers for siRNA delivery, selective targeting, and enhanced biostability in MCF-7 cell lines</ArticleTitle>
    <FirstPage>240</FirstPage>
    <LastPage>253</LastPage>
    <ELocationID EIdType="doi">10.34172/mj.026.35311</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hashem</FirstName>
        <LastName>Yaghoubi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3449-3037</Identifier>
      </Author>
      <Author>
        <FirstName>Mehran</FirstName>
        <LastName>Noruzpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-3447-0035</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/mj.026.35311</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Background. Nanotechnology addresses the challenge of targeted drug and nucleic acid delivery to cancer cells through the design of intelligent carriers. This study was conducted to design a smart nanocarrier based on PCL/Chitosan/PEG functionalized with hyaluronic acid (HA) for the delivery of siRNA to breast cancer cells (MCF-7).  Methods. The physicochemical properties of the synthesized nanoparticles were analyzed using 1H-NMR and TGA. Zeta potential and nanoparticle size were assessed using dynamic light scattering (DLS), confirming successful synthesis.  Results. DLS analysis revealed that after loading siRNA-FAM, the size of PCPH nanoparticles increased from 201±7 nm to 294±9 nm, and that of PEI nanoparticles from 186±11 nm to 220±6 nm. Meanwhile, siRNA loading reduced the zeta potential of PCPH nanoparticles from +1.72±0.52 mV to -2.5±0.50 mV. The results showed that at neutral pH, PEI/siRNA-FAM exhibited significantly higher release than PCPH after 480 minutes, whereas in an acidic environment, both nanoparticles released siRNA-FAM at a similar rate. Cytotoxicity assessment indicated that PCPH nanoparticles carrying siRNA had significant inhibitory effects on the growth of MCF-7 cells. The results of gel electrophoresis confirmed that PCPH nanoparticles effectively interacted electrostatically with siRNA-FAM, neutralizing its negative charge and halting its migration in the gel.  Conclusion. PCL-Chitosan-PEG-HA nanoparticles serve as a biocompatible and targeted system for siRNA delivery to cancer cells, demonstrating high efficiency in targeted gene therapy.  Practical Implications. The findings of this study represent a significant step toward more personalized and effective cancer treatments using nanotechnology.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Breast Cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chitosan</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hyaluronic Acid</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nanotechnology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MCF-7</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Targeted Gene Therapy</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>